Literature DB >> 18680230

Development of hepatorenal syndrome in bile duct ligated rats.

Regina M Pereira1, Robson A S dos Santos, Eduardo A Oliveira, Virginia H R Leite, Filipi L C Dias, Alysson S Rezende, Lincoln P Costa, Luciola S Barcelos, Mauro M Teixeira, Ana Cristina Simoes e Silva.   

Abstract

AIM: To evaluate in bile duct ligated rats whether there were progressive alterations of renal function without changes in histopathology.
METHODS: Male Wistar rats were submitted to sham-surgery or bile duct ligation (BDL) and divided according to the post-procedure time (2, 4 and 6-wk). To determine renal function parameters, rats were placed in metabolic cages and, at the end of the experiment, blood and urine samples were obtained. Histology and hydroxyproline content were analyzed in liver and renal tissue.
RESULTS: Rats with 2 wk of BDL increased free water clearance (P = 0.02), reduced urinary osmolality (P = 0.03) and serum creatinine (P = 0.01) in comparison to the sham group. In contrast, rats at 6 wk of BDL showed features of HRS, including significant increase in serum creatinine and reductions in creatinine clearance, water excretion and urinary sodium concentration. Rats with 4 wk of BDL exhibited an intermediate stage of renal dysfunction. Progressive hepatic fibrosis according to post-procedure time was confirmed by histology. The increased levels of liver hydroxyproline contrasted with the absence of structural changes in the kidney, as assessed by histology and unchanged hydroxyproline content in renal tissue.
CONCLUSION: Our data show that BDL produced progressive renal dysfunction without structural changes in the kidney, characterizing HRS. The present model will be useful to understand the pathophysiology of HRS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680230      PMCID: PMC2731277          DOI: 10.3748/wjg.14.4505

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

Review 1.  [Experimental models of portal hypertension].

Authors:  F Oberti; E Vuillemin; J Fort; P Calès
Journal:  Gastroenterol Clin Biol       Date:  2000-10

2.  Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles.

Authors:  YiLin Ren; Jeffrey L Garvin; Oscar A Carretero
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

Review 3.  Hepatorenal syndrome.

Authors:  Andrés Cárdenas; Pere Gines
Journal:  Clin Liver Dis       Date:  2006-05       Impact factor: 6.126

Review 4.  The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator.

Authors:  Ana Cristina Simões e Silva; Sérgio Veloso Brant Pinheiro; Regina Maria Pereira; Anderson José Ferreira; Robson Augusto Souza Santos
Journal:  Mini Rev Med Chem       Date:  2006-05       Impact factor: 3.862

5.  Effect of intratubular application of angiotensin 1-7 on nephron function.

Authors:  V Vallon; K Richter; N Heyne; H Osswald
Journal:  Kidney Blood Press Res       Date:  1997       Impact factor: 2.687

Review 6.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

7.  Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.

Authors:  G Paizis; C Tikellis; M E Cooper; J M Schembri; R A Lew; A I Smith; T Shaw; F J Warner; A Zuilli; L M Burrell; P W Angus
Journal:  Gut       Date:  2005-09-15       Impact factor: 23.059

Review 8.  The hyperdynamic circulation in cirrhosis: an overview.

Authors:  L Blendis; F Wong
Journal:  Pharmacol Ther       Date:  2001-03       Impact factor: 12.310

Review 9.  Update on ascites and hepatorenal syndrome.

Authors:  P Gentilini; F Vizzutti; A Gentilini; M Zipoli; M Foschi; R G Romanelli
Journal:  Dig Liver Dis       Date:  2002-08       Impact factor: 4.088

10.  Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis.

Authors:  Chandana B Herath; Fiona J Warner; John S Lubel; Rachael G Dean; Zhiyuan Jia; Rebecca A Lew; A Ian Smith; Louise M Burrell; Peter W Angus
Journal:  J Hepatol       Date:  2007-04-02       Impact factor: 25.083

View more
  16 in total

1.  Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression.

Authors:  Er-Liang Kong; Jin-Min Zhang; Ni An; Yong Tao; Wei-Feng Yu; Fei-Xiang Wu
Journal:  J Cell Commun Signal       Date:  2018-06-07       Impact factor: 5.782

2.  Holoturia arenicola extract modulates bile duct ligation-induced oxidative stress in rat kidney.

Authors:  Sohair R Fahmy; Ayman S Mohamed
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.

Authors:  Michael M Yeboah; Md Abdul Hye Khan; Marla A Chesnik; Melissa Skibba; Lauren L Kolb; John D Imig
Journal:  Nephrol Dial Transplant       Date:  2018-08-01       Impact factor: 5.992

4.  Defective renal autoregulation in the chronic bile duct ligation model of liver failure.

Authors:  Tomchika Maoka; Tetsuya Kawata; Takao Koike; Toshio Mochizuki; Jurgen Schnermann; Seiji Hashimoto
Journal:  Clin Exp Nephrol       Date:  2018-03-07       Impact factor: 2.801

5.  The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.

Authors:  M A Aller; I Prieto; S Argudo; F de Vicente; L Santamaría; M P de Miguel; J L Arias; J Arias
Journal:  Int J Inflam       Date:  2010-10-05

6.  N-acetyl-l-cysteine Prevents Bile Duct Ligation Induced Renal Injury by Modulating Oxidative Stress.

Authors:  Rajat Sandhir; Sandeep Kaur; Saurabh Dhanda
Journal:  Indian J Clin Biochem       Date:  2016-12-01

7.  Bile duct ligation in rats: a reliable model of hepatorenal syndrome?

Authors:  Stelios F Assimakopoulos; Constantine E Vagianos
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

8.  D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure?

Authors:  Marek Saracyn; Robert Zdanowski; Marek Brytan; Grzegorz Kade; Zbigniew Nowak; Janusz Patera; Przemysław Dyrla; Jerzy Gil; Zofia Wańkowicz
Journal:  Med Sci Monit       Date:  2015-05-22

9.  Abnormal Expression of Urea Transporter Protein in a Rat Model of Hepatorenal Syndrome Induced by Succinylated Gelatin.

Authors:  Weiping Song; Xiaolong Qi; Wenhui Zhang; Yingying Zhao; Yan Cao; Fei Wang; Changqing Yang
Journal:  Med Sci Monit       Date:  2015-09-28

Review 10.  Do Biliary Salts Have Role on Acute Kidney Injury Development?

Authors:  Thiago Gomes Romano; Jose Mauro Vieira Junior
Journal:  J Clin Med Res       Date:  2015-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.